Medicare Enrolled

Dr. Henry Xiong, M.D.

Hematology & Oncology · Fort Worth, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
800 W MAGNOLIA AVE, Fort Worth, TX 76104
8177597000
In practice since 2006 (19 years)
NPI: 1518910561 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Xiong from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Xiong? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Xiong

Dr. Henry Xiong is a hematology & oncology specialist in Fort Worth, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Xiong performed 67,687 Medicare services across 1,283 unique beneficiaries.

Between the years covered by Open Payments, Dr. Xiong received a total of $89,240 from 55 pharmaceutical and/or device companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Xiong is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in TX $89,240 industry payments

Medicare Practice Summary

Medicare Utilization ↗
67,687
Medicare services
Top 14% in TX for hematology & oncology
1,283
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,562 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Filgrastim injection (Nivestym) for white blood cells 23,400 $0 $2
Anti-nausea injection (fosaprepitant) 18,600 $0 $5
Iron infusion (Injectafer) 11,250 $1 $3
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg 4,670 $23 $135
Dexamethasone injection (steroid) 1,664 $0 $5
Epoetin alfa injection (Procrit) for anemia 1,480 $6 $28
Anti-nausea injection (Aloxi/palonosetron) 1,440 $1 $52
Immune globulin infusion (Octagam) 1,410 $34 $100
Injection, fluorouracil, 500 mg 640 $2 $5
Injection of additional new drug or substance into vein 426 $12 $70
Office visit, established patient, complex (40-54 min) 386 $135 $350
Administration of chemotherapy into vein, 1 hour or less 239 $102 $412
Drug injection, under skin or into muscle 224 $11 $60
Office visit, established patient (30-39 min) 211 $94 $275
Injection, granisetron hydrochloride, 100 mcg 201 $0 $10
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 178 $23 $100
Administration of additional new drug or substance into vein, 1 hour or less 178 $51 $202
Hospital follow-up visit, moderate complexity 111 $62 $175
Administration of chemotherapy into vein, each additional hour 109 $22 $93
Office visit, established patient (20-29 min) 102 $61 $175
Hospital follow-up visit, high complexity 95 $90 $250
Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month 80 $48 $160
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 78 $49 $190
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l 63 $133 $450
Injection, diphenhydramine hcl, up to 50 mg 63 $1 $10
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 61 $16 $60
CT scan of abdomen and pelvis with contrast 57 $172 $681
Ct scan of chest with contrast 54 $46 $401
Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month 44 $37 $120
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion 35 $16 $60
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 25 $1 $5
Advance care planning consultation, first 30 min 24 $65 $250
Initial hospital admission, high complexity 18 $135 $500
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle 15 $27 $105
New patient office visit, complex (60-74 min) 15 $172 $500
Nuclear medicine study from skull base to mid-thigh with ct scan 14 $1,075 $4,069
New patient office visit (45-59 min) 14 $115 $400
Initial hospital admission, moderate complexity 13 $101 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
19.3% high complexity
78.8% medium
1.9% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$89,240
Total received (2018-2024)
Avg $12,749/year across 7 years
Top 8% in TX for hematology & oncology
55
Companies
222
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$71,914 (80.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,483 (10.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,843 (8.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,624
2023
$9,175
2022
$8,009
2021
$4,604
2020
$4,376
2019
$19,199
2018
$42,252

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Eisai Inc.
$20,431
Bayer HealthCare Pharmaceuticals Inc.
$8,017
TESARO, Inc.
$6,216
Ipsen Biopharmaceuticals, Inc
$5,497
AstraZeneca Pharmaceuticals LP
$5,180
E.R. Squibb & Sons, L.L.C.
$5,035
Lilly USA, LLC
$5,031
Kite Pharma, Inc.
$4,780
Exelixis Inc.
$4,610
Seagen Inc.
$4,414
Taiho Oncology, Inc.
$4,180
EISAI INC.
$3,867
TAIHO ONCOLOGY, INC.
$2,200
Novartis Pharmaceuticals Corporation
$2,081
ARRAY BIOPHARMA INC
$1,913
F. Hoffmann-La Roche AG
$1,501
Celgene Corporation
$309
Daiichi Sankyo Inc.
$265
GlaxoSmithKline, LLC.
$250
Puma Biotechnology, Inc.
$237
Merck Sharp & Dohme Corporation
$235
Astellas Pharma US Inc
$222
Sirtex Medical Inc
$210
Takeda Pharmaceuticals U.S.A., Inc.
$185
Stryker Corporation
$147
Janssen Biotech, Inc.
$142
Tempus AI, Inc
$136
PUMA BIOTECHNOLOGY, INC.
$136
PFIZER INC.
$133
Amgen Inc.
$131
Gilead Sciences, Inc.
$128
Genmab U.S., Inc.
$125
AbbVie, Inc.
$124
Stemline Therapeutics Inc.
$120
GENZYME CORPORATION
$120
Blueprint Medicines Corporation
$119
Verastem, Inc.
$115
ADC Therapeutics America, Inc.
$111
Regeneron Healthcare Solutions, Inc.
$104
ASD Specialty Healthcare, LLC
$81
Epizyme, Inc.,
$64
Alexion Pharmaceuticals, Inc.
$53
Rigel Pharmaceuticals, Inc.
$39
Sun Pharmaceutical Industries Inc.
$39
Genentech USA, Inc.
$37
ABBVIE INC.
$25
Apellis Pharmaceuticals, Inc.
$24
BeiGene USA, Inc.
$22
Incyte Corporation
$20
AIMMUNE THERAPEUTICS, INC.
$16
Seattle Genetics, Inc.
$14
Pharmacyclics LLC, An AbbVie Company
$14
Aurobindo Pharma USA, Inc.
$12
Clovis Oncology, Inc.
$12
Helsinn Therapeutics (U.S.), Inc.
$11
Top 3 companies account for 38.8% of total payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · AYVAKIT · Abraxane · Avastin · BRAFTOVI · BRUKINSA · CALQUENCE · CHANTIX · CYRAMZA · Cabometyx · Copiktra · DARZALEX · ELIQUIS · ENHERTU · ERLEADA · Empaveli · Enhertu · Erleada · Folotyn · IMBRUVICA · IMFINZI · INJECTAFER · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · LENVIMA · LIBTAYO · LONSURF · LUTATHERA · Lenvima · Lonsurf · Lupron · NERLYNX · NINLARO · Nerlynx · Nexavar · Nplate · Nubeqa · OJJAARA · OPDIVO · Odomzo · Onivyde · Orserdu · Pomalyst · REBLOZYL · Revlimid · Rubraca · SIR-Spheres Microspheres · SOMATULINE DEPOT · Somatuline Depot · Stivarga · TAZVERIK · TRIATHLON · TUKYSA · Tavalisse · Tecentriq · Tivdak · Trodelvy · Ultomiris · VERZENIO · Venclexta · XALKORI · XTANDI · Yescarta · ZEJULA · ZENPEP
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (81%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for hematology & oncology in TX.

Equivalent to $132 per 100 Medicare services performed
Looking for a hematology & oncology specialist in Fort Worth?
Compare hematology & oncology specialists in the Fort Worth area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
47
Per 100K population
2.2
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Xiong is a mixed practice specialist, with above-average Medicare volume (top 14% in TX), with consulting-driven industry engagement in the top 8% of TX peers, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Xiong experienced with filgrastim injection (nivestym) for white blood cells?
Based on Medicare claims data, Dr. Xiong performed 23,400 filgrastim injection (nivestym) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Xiong receive payments from pharmaceutical companies?
Yes. Dr. Xiong received a total of $89,240 from 55 companies across 222 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Xiong's costs compare to other hematology & oncology specialists in Fort Worth?
Dr. Xiong's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Xiong) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →